Literature DB >> 20347021

Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase.

O Tenberken1, H Thiermann, F Worek, G Reiter.   

Abstract

The easy accessibility to highly toxic OP (organophosphorus)-type chemical warfare agents (nerve agents) underlines the necessity for an effective medical treatment. Acute OP toxicity is primarily caused by inhibition of acetylcholinesterase (AChE, EC 3.1.1.7). Reactivators (oximes) of inhibited AChE are a mainstay of treatment. However, the commercially available compounds, obidoxime and pralidoxime, are considered rather ineffective against various nerve agents, including tabun. OP-type chemical warfare agents include an asymmetrical P-atom and consist of at least two stereoisomers. Previous studies with the nerve agents sarin and soman showed marked differences between (-)- and (+)-P isomers regarding AChE inhibition and stability in biological matrices. Hence, stereoselectivity is a key parameter for the development of optimized treatment. In the present study, the tabun enantiomers were isolated by semi-preparative liquid-chromatography (LC) with offline analysis by GC-PCI-MS and final characterization of optical purity (99.98% (-)-tabun and 99.83% (+)-tabun) and specific optical rotation. The inhibition and reactivation kinetics of the tabun enantiomers were determined with human and swine AChE and the aging kinetics with human AChE. The results show a large difference in the inhibitory potency between (-)- and (+)-tabun. The determination of reactivation and aging kinetics indicates that both reactions are at least in part determined by the residual (-)-tabun contamination (0.17%) of the (+)-tabun preparation. These data provide further insight into the kinetic interactions between tabun enantiomers and AChE and may contribute to the development of more effective treatment options. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347021     DOI: 10.1016/j.toxlet.2010.03.012

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Catalytic characteristics of plant-esterase from wheat flour.

Authors:  Chang-jun Hou; Kun He; Li-min Yang; Dan-qun Huo; Mei Yang; Shun Huang; Liang Zhang; Cai-hong Shen
Journal:  World J Microbiol Biotechnol       Date:  2011-08-04       Impact factor: 3.312

Review 2.  Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.

Authors:  A R Satvik Iyengar; Abhay H Pande
Journal:  Protein J       Date:  2016-12       Impact factor: 2.371

3.  Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.

Authors:  Eugénie Carletti; Lawrence M Schopfer; Jacques-Philippe Colletier; Marie-Thérèse Froment; Florian Nachon; Martin Weik; Oksana Lockridge; Patrick Masson
Journal:  Chem Res Toxicol       Date:  2011-04-18       Impact factor: 3.739

4.  Mass spectrometry method to identify aging pathways of Sp- and Rp-tabun adducts on human butyrylcholinesterase based on the acid labile P-N bond.

Authors:  Wei Jiang; John R Cashman; Florian Nachon; Patrick Masson; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2013-01-23       Impact factor: 4.849

5.  Chiral separation of G-type chemical warfare nerve agents via analytical supercritical fluid chromatography.

Authors:  Shane A Kasten; Steven Zulli; Jonathan L Jones; Thomas Dephillipo; Douglas M Cerasoli
Journal:  Chirality       Date:  2014-10-09       Impact factor: 2.437

6.  Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro.

Authors:  Anja Köhler; Benjamin Escher; Laura Job; Marianne Koller; Horst Thiermann; Arne Skerra; Franz Worek
Journal:  Arch Toxicol       Date:  2021-06-23       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.